Onset of action of olanzapine-fluoxetine combination for treatment-resistant depression

被引：0
|
作者：
Dube, S
Andersen, SW
Briggs, SD
Van Campen, LE
Sanger, TM
Thase, ME
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [41] A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder
    Zanarini, MC
    Frankenburg, FR
    Parachini, EA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (07) : 903 - 907
  • [42] Quetiapine-related Rabbit syndrome in a Patient with Bipolar Depression and Treated with Olanzapine-fluoxetine Combination
    Belli, H.
    Akbudak, M.
    Bal, Z. E.
    [J]. WEST INDIAN MEDICAL JOURNAL, 2017, 66 (01): : 171 - 172
  • [43] Fluoxetine and olanzapine for resistant depression
    Benazzi, F
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (01): : 155 - 155
  • [44] Olanzapine plus venlafaxine in treatment-resistant depression
    Devarajan, S
    Dursun, SM
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (04) : 434 - 435
  • [45] Olanzapine-fluoxetine combination versus lamotrigine for bipolar I depression: Quality of life outcome analysis
    Brown, E.
    Orth, P.
    Houston, J.
    Stensland, M.
    Ahi, J.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S190 - S190
  • [46] The effects of chronic fluoxetine, olanzapine or olanzapine-fluoxetine combination treatment on the expression of brain derived neurotrophic factor levels in chronically stressed rats
    Donat, EO
    Gozen, O
    Gonul, AS
    Koylu, E
    Eker, C
    Akdeniz, E
    Vahip, S
    Pogun, S
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S222 - S222
  • [47] Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
    Brunner, Elizabeth
    Tohen, Mauricio
    Osuntokun, Olawale
    Landry, John
    Thase, Michael E.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 (11) : 2549 - 2559
  • [48] Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder
    Elizabeth Brunner
    Mauricio Tohen
    Olawale Osuntokun
    John Landry
    Michael E Thase
    [J]. Neuropsychopharmacology, 2014, 39 : 2549 - 2559
  • [49] Olanzapine/Fluoxetine Combination in Patients With Treatment-Resistant Depression: Rapid Onset of Therapeutic Response and Its Predictive Value for Subsequent Overall Response in a Pooled Analysis of 5 Studies
    Tohen, Mauricio
    Case, Michael
    Trivedi, Madhukar H.
    Thase, Michael E.
    Burke, Scott J.
    Durell, Todd M.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (04) : 451 - 462
  • [50] Early Weight Gain as a Predictor of Substantial Weight Gain With Olanzapine/Fluoxetine Combination An Analysis of 2 Adult Studies in Treatment-Resistant Depression
    Degenhardt, Elisabeth K.
    Jamal, Hassan H.
    Tormey, Susan
    Case, Michael
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (03) : 337 - 340
12345